Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma

NCT00053326 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Recurrent Neuroblastoma

Interventions

DRUG: fenretinide
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)